VIA EDGAR
December 18, 2013
Mr. Ruairi Regan
Division of Corporation Finance
United States Securities and Exchange Commission
Re: | Amedisys, Inc. |
Form 10-K for the Fiscal Year Ended December 31, 2012
Filed March 12, 2013
Form 10-Q for Quarterly Period Ended September 30, 2013
Filed November 12, 2013
File No. 000-24260
Dear Mr. Regan:
Thank you for our recent phone conversation regarding the comments of the staff of the United States Securities and Exchange Commission regarding the above-listed filings. This letter confirms our request that Amedisys, Inc. be given an extension until January 20, 2014 to respond to the comments.
Please contact me at (225) 299-3209 should you have any questions.
Sincerely, |
/s/ David R. Bucey |
David R. Bucey |
General Counsel and Corporate Secretary |
Amedisys, Inc. |